In addition to network pathway analyses in this study demonstrating that miR-122-5p may regulate several matrix metalloproteinases implicated in the pathogenesis of AAA, multiple studies have confirmed both MMP-2 and MMP-9 as targets of miR-122-5p [33, 34]. The gene discussed is MMP9; the disease is triple-A syndrome.